Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions.

Adverse drug effects (ADEs) are one of the leading causes of death in developed countries and are the main reason for drug recalls from the market, whereas the ADEs that are associated with action on the cardiovascular system are the most dangerous and widespread. The treatment of human diseases oft...

Full description

Bibliographic Details
Main Authors: Sergey Ivanov, Alexey Lagunin, Dmitry Filimonov, Vladimir Poroikov
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-07-01
Series:PLoS Computational Biology
Online Access:https://doi.org/10.1371/journal.pcbi.1006851
_version_ 1819029936405479424
author Sergey Ivanov
Alexey Lagunin
Dmitry Filimonov
Vladimir Poroikov
author_facet Sergey Ivanov
Alexey Lagunin
Dmitry Filimonov
Vladimir Poroikov
author_sort Sergey Ivanov
collection DOAJ
description Adverse drug effects (ADEs) are one of the leading causes of death in developed countries and are the main reason for drug recalls from the market, whereas the ADEs that are associated with action on the cardiovascular system are the most dangerous and widespread. The treatment of human diseases often requires the intake of several drugs, which can lead to undesirable drug-drug interactions (DDIs), thus causing an increase in the frequency and severity of ADEs. An evaluation of DDI-induced ADEs is a nontrivial task and requires numerous experimental and clinical studies. Therefore, we developed a computational approach to assess the cardiovascular ADEs of DDIs. This approach is based on the combined analysis of spontaneous reports (SRs) and predicted drug-target interactions to estimate the five cardiovascular ADEs that are induced by DDIs, namely, myocardial infarction, ischemic stroke, ventricular tachycardia, cardiac failure, and arterial hypertension. We applied a method based on least absolute shrinkage and selection operator (LASSO) logistic regression to SRs for the identification of interacting pairs of drugs causing corresponding ADEs, as well as noninteracting pairs of drugs. As a result, five datasets containing, on average, 3100 potentially ADE-causing and non-ADE-causing drug pairs were created. The obtained data, along with information on the interaction of drugs with 1553 human targets predicted by PASS Targets software, were used to create five classification models using the Random Forest method. The average area under the ROC curve of the obtained models, sensitivity, specificity and balanced accuracy were 0.837, 0.764, 0.754 and 0.759, respectively. The predicted drug targets were also used to hypothesize the potential mechanisms of DDI-induced ventricular tachycardia for the top-scoring drug pairs. The created five classification models can be used for the identification of drug combinations that are potentially the most or least dangerous for the cardiovascular system.
first_indexed 2024-12-21T06:22:11Z
format Article
id doaj.art-71921499dd3746d9972d2e56ef5c52a7
institution Directory Open Access Journal
issn 1553-734X
1553-7358
language English
last_indexed 2024-12-21T06:22:11Z
publishDate 2019-07-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Computational Biology
spelling doaj.art-71921499dd3746d9972d2e56ef5c52a72022-12-21T19:13:13ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582019-07-01157e100685110.1371/journal.pcbi.1006851Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions.Sergey IvanovAlexey LaguninDmitry FilimonovVladimir PoroikovAdverse drug effects (ADEs) are one of the leading causes of death in developed countries and are the main reason for drug recalls from the market, whereas the ADEs that are associated with action on the cardiovascular system are the most dangerous and widespread. The treatment of human diseases often requires the intake of several drugs, which can lead to undesirable drug-drug interactions (DDIs), thus causing an increase in the frequency and severity of ADEs. An evaluation of DDI-induced ADEs is a nontrivial task and requires numerous experimental and clinical studies. Therefore, we developed a computational approach to assess the cardiovascular ADEs of DDIs. This approach is based on the combined analysis of spontaneous reports (SRs) and predicted drug-target interactions to estimate the five cardiovascular ADEs that are induced by DDIs, namely, myocardial infarction, ischemic stroke, ventricular tachycardia, cardiac failure, and arterial hypertension. We applied a method based on least absolute shrinkage and selection operator (LASSO) logistic regression to SRs for the identification of interacting pairs of drugs causing corresponding ADEs, as well as noninteracting pairs of drugs. As a result, five datasets containing, on average, 3100 potentially ADE-causing and non-ADE-causing drug pairs were created. The obtained data, along with information on the interaction of drugs with 1553 human targets predicted by PASS Targets software, were used to create five classification models using the Random Forest method. The average area under the ROC curve of the obtained models, sensitivity, specificity and balanced accuracy were 0.837, 0.764, 0.754 and 0.759, respectively. The predicted drug targets were also used to hypothesize the potential mechanisms of DDI-induced ventricular tachycardia for the top-scoring drug pairs. The created five classification models can be used for the identification of drug combinations that are potentially the most or least dangerous for the cardiovascular system.https://doi.org/10.1371/journal.pcbi.1006851
spellingShingle Sergey Ivanov
Alexey Lagunin
Dmitry Filimonov
Vladimir Poroikov
Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions.
PLoS Computational Biology
title Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions.
title_full Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions.
title_fullStr Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions.
title_full_unstemmed Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions.
title_short Assessment of the cardiovascular adverse effects of drug-drug interactions through a combined analysis of spontaneous reports and predicted drug-target interactions.
title_sort assessment of the cardiovascular adverse effects of drug drug interactions through a combined analysis of spontaneous reports and predicted drug target interactions
url https://doi.org/10.1371/journal.pcbi.1006851
work_keys_str_mv AT sergeyivanov assessmentofthecardiovascularadverseeffectsofdrugdruginteractionsthroughacombinedanalysisofspontaneousreportsandpredicteddrugtargetinteractions
AT alexeylagunin assessmentofthecardiovascularadverseeffectsofdrugdruginteractionsthroughacombinedanalysisofspontaneousreportsandpredicteddrugtargetinteractions
AT dmitryfilimonov assessmentofthecardiovascularadverseeffectsofdrugdruginteractionsthroughacombinedanalysisofspontaneousreportsandpredicteddrugtargetinteractions
AT vladimirporoikov assessmentofthecardiovascularadverseeffectsofdrugdruginteractionsthroughacombinedanalysisofspontaneousreportsandpredicteddrugtargetinteractions